IntroductionHepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality. Because HCC typically occurs in patients with advanced live
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and ranks second among global causes of cancer-related death (1). The epidemiological a
Hepatitis C virus (HCV) infection is one of the major causes of end-stage liver disease and hepatocellular carcinoma (HCC). Before the use of direct acting anti